ABSTRACT There are three specific regions in the Amyloid beta (Ab) peptide sequence where variations cause enhanced toxicity in Alzheimer's disease: the N-terminus, the central salt bridge, and the C-terminus. Here, we investigate if there is a close conformational connection between these three regions, which may suggest a concerted mechanism of toxicity. We measure the effects of Zn 2þ and curcumin on Ab 40 , and compare these with their previously reported effects on Ab 42 . Ab 42 and Ab 40 differ only near the C-terminus, where curcumin interacts, while Zn 2þ interacts near the N-terminus. Therefore, this comparison should help us differentiate the effect of modulating the C-and the N-termini. We find that curcumin allows fibril-like structures containing the salt bridge to emerge in the mature Ab 40 aggregates, but not in Ab 42 . In contrast, we find no difference in the effects of Zn þ2 on Ab 40 and Ab 42 . In the presence of Zn
INTRODUCTION
Toxicity associated with amyloid beta (Ab) aggregation is linked to Alzheimer's disease (1) (2) (3) (4) , but the mechanism of toxicity has remained unknown. Nature provides indications that Ab toxicity has a structural origin. For example, Ab 40 and Ab 42 are the two major isoforms of Ab found in the brain plaques of Alzheimer's patients. They are identical except for the two extra amino acids at the C-terminus of Ab 42 , which make it fold differently (5) (6) (7) (8) (9) , and also make it more aggregation-prone and toxic (10) . At least two other regions also seem to be important for determining toxicity. Mutations in Ab that lead to early onset AD almost exclusively map to one of these two regions: the N-terminus (first seven residues, which are loosely structured at best); or the central region (residues 21-23) (11) (12) (13) , which in wild-type Ab 40 , contains a salt bridge. It is interesting to hypothesize that these three regions constitute conformationally connected arms of the same toxic mechanism.
Curcumin, a biphenolic compound known to interact with Ab and alter its properties (14) (15) (16) (17) (18) , provides a natural handle to test this hypothesis. Curcumin is known to modulate Ab toxicity (17, 19, 20) , and its most prominent site of interaction is the C-terminal region, though it also interacts with some residues at the N-terminal region (as shown for Ab 42 (21, 22) ). Zn 2þ , another well-known modulator of Ab aggregation and toxicity (23, 24) , provides an ideal comparison. It is thought to interact almost exclusively with the Histidine residues near the N-terminal (25) (26) (27) . It therefore should have very similar effects on Ab 42 and Ab 40 . Both Zn 2þ and curcumin are known to interact with the toxic oligomers of Ab 42 , and sequester them by accelerating their precipitation, which yield similar nonfibrillar aggregates. Significantly, the salt bridge between Lys 28 and Asp 23 , a key structural feature of mature C-terminal-amidated Ab fibrils (28) , is lacking in these Ab 42 aggregates (21, 29) . It was inferred that these agents disrupt the salt bridge. Notably, a large fraction of the mutations associated with early onset AD occurs in the two neighboring residues (E22 and D23) in the salt-bridge region (13) . We note that recent works on two different preparations of the Ab 42 fibril have suggested a different salt bridge between K28 and the terminal carboxylate (9, 30) . However, in alternative preparations, such as those where the C-terminal is amidated, Lys 28 does form a salt bridge with D23 (29) . In addition, we have also shown that there are significant structural differences between the transient toxic oligomers and the less toxic mature fibrils of Ab 40 in the salt-bridge region (1) . Hence, the perturbation of the salt bridge may be directly linked to the alteration of toxicity.
The above-mentioned reports suggested that the terminal regions of Ab 42 can control the fate of the central salt bridge, but they could not rule out direct involvement of Zn 2þ or curcumin with the central region. However, if the effect of curcumin on the salt bridge is different for Ab 40 and Ab 42 , then it will strongly indicate that the state of the residues at the C-terminus has a strong role to play in determining the state of the salt bridge. Here, we follow the fate of the salt bridge in separate preparations of Ab 40 incubated with curcumin and Zn 2þ , respectively, using solid-state nuclear magnetic resonance (ssNMR) tools. In addition, we follow the size of the soluble aggregates (with fluorescence correlation spectroscopy, FCS), the mesoscale morphology of the aggregates (with transmission electron microscopy, TEM), and the toxicity of Ab 40 . We then compare these results with those reported for Ab 42 . We draw three important inferences from our results: first, the interaction of curcumin with the C-terminal of the peptide can determine the fate of the salt bridge far away in the sequence; second, the fate of the salt bridge is associated with the toxicity of the peptide, and the mesoscale morphology of the aggregates; and third, a small molecule such as curcumin can act like a catalyst in the Ab 40 aggregation pathway, changing only the nature of the intermediate, but leaving the end-state nearly unaffected.
MATERIALS AND METHODS

Materials
Rink amide MBHA resin LL, Fmoc (N-(9-fluorenyl) methoxycarbonyl) protected amino acids, O-benzotriazole-N,N,N,N-tetramethyluroniumhexafluoro phosphate, and triisopropylsilane were purchased from Advanced ChemTech (Louisville, KY). 1-Hydroxybenzotriazole, N,N-dimethylformamide, collidine, TFA, tert-butyl methyl ether, acetonitrile, and isopropyl alcohol were obtained from S.D. Fine Chemicals (Mumbai, India). 1,8-Diazabicyclo[5.4.0] undec-7-ene, N-methyl morpholine, piperidine, hexafluoroisopropanol, thio-T, DMSO, 5 (6)-carboxytetramethylrhodamine N-succinimidyl ester, and the buffer salts are purchased from Sigma-Aldrich (St. Louis, MO). Phenol, N,N-diisopropylcarbodiimide, ethane dithiol, thioanisole, and trifluoroethanol are purchased from Fluka (Sigma-Aldrich). The isotopically labeled amino acids were purchased from Euriso-top (St. Aubin, France). All animal experimental protocols were approved by the Institute Animal Ethics committee.
Ab 40 sample preparation
Wild-type Ab 40 and three different schemes of 15 N-, 13 C-labeled Ab 40 were synthesized in a solid phase peptide synthesizer and further purified by a reverse-phase HPLC. The scheme 1 (S1) Ab 40 40 were diluted five times in HEPES buffer (pH~7.4) containing 500 mM ZnCl 2 , giving a final solution that had 400 mM of both ZnCl 2 and the respective peptides. For aggregates of Ab 40 in the presence of curcumin, a 4 mM stock solution of curcumin was also prepared by dissolving it in pH 11.0 water. A quantity of 1.5 mL of Ab stock (2 mM), 150 mL of freshly prepared curcumin stock (4 mM), and 7.5 mL of Rhodamine-labeled Ab (RAb) (100 mM) were premixed in pH 11 for 5 min, and immediately diluted with 5.85 mL HEPES buffer at pH 7.4 such that total volume was 7.5 mL. This final solution containing 400 mM Ab, 80 mM curcumin, and 100 nM RAb was incubated at room temperature (25 C) for four days with mild rotation (10 rpm). For making the early aggregates of Ab 40 in the presence of curcumin, we prepared the sample in a similar way to that described above, but with centrifugation (2700 Â g) after 30 min of pH drop (from pH 11 to 7.4). The final pH of the solution was 7.4. The precipitate was lyophilized before packing into the NMR rotor. To grow Ab-Cur aggregates at lower concentrations (40 mM of Ab and 8 mM of curcumin), freshly prepared stock solutions of Ab and curcumin (as described above) were diluted 10 times at pH 11, premixed with 7.5 mL RAb (100 mM) for 5 min at pH 11, followed by dilution with HEPES buffer (up to 7.5 mL, pH 7.4), and incubation at room temperature (25 C) for four days with mild rotation (10 rpm).
Fluorescence correlation spectroscopy
Size of the Ab species in solution was determined by FCS measurements following procedures similar to Sengupta et al. (31) . The measurements were performed with an instrument constructed in-house (31) . FCS data were fitted with a discrete component diffusion model using Origin 7.5 software (OriginLab, Northampton, MA). The diffusion times were converted to hydrodynamic radii (R h ) using rhodamine B (assumed R h ¼ 0.57 nm) as a calibrant. We used the MEMFCS (32) fitting routine developed specifically for such measurements to obtain a size distribution from the FCS data in a model-free manner.
TEM
Ab 40 (400 mM) and Ab 40 -Cur (either 400 mM Ab 40 þ 80 mM curcumin or 40 mM Ab 40 þ 8 mM curcumin) were aggregated for four days in HEPES buffer. Ten milliliters of these solutions were added to carbon-coated, 100-mesh copper grids (Electron Microscopy Sciences, Hatfield, PA). The extra water was blotted with tissue paper after 2-3 min, and a few mild washings were done with Milli-Q water (Millipore, Billerica, MA). A quantity of 0.1% of uranyl acetate was added for 5 min for sample staining. The grids were dried under an infrared lamp and examined in the LIBRA 120 EFTEM (Carl Zeiss, Oberkochen, Germany).
Solid-state NMR
The ssNMR measurements were performed on amyloid aggregates of Ab 40 peptides (400 mM) containing isotopically labeled amino acids at specific positions grown in the presence and absence of Zn 2þ and curcumin. The aggregates were pelleted by ultracentrifugation (2700 Â g at 20 C), washed with deionized water twice, rapidly frozen using liquid nitrogen, and lyophilized. Powders containing Ab 40 peptides were packed as such without any rehydration into either 2.5, 4, or 3.2 mm magic-angle-spinning (MAS) rotors.
All the ssNMR measurements were performed in a 700 MHz model No. AVIII NMR spectrometer (Bruker, Billerica, MA) using 2.5, 3.2, or 4 mm triple-resonance MAS probes. Cross polarization from 1 H to 13 C was implemented using a linear ramped radio-frequency field (33) C dipolar decoupling. Two-dimensional (2D) 13 C-13 C through-space NMR spectra were recorded using a second-order dipolar recoupling, phase-alternated recoupling irradiation scheme (PARIS-xy) (35) with m ¼ 1, N ¼ 2. Mixing periods of 400 and 100 ms (n r ¼ 15 kHz) were used for S 1 Ab. For the S 2 peptide, 2D 13 C- 13 C through-space correlation NMR spectra were recorded with a PARIS-xy (m ¼ 1, N ¼ 0.5) recoupling scheme using mixing periods of 40 and 400 ms at a n r of 15 kHz.
NMR data analysis
All one-dimensional (1D) spectra were processed and analyzed using the software TopSpin 2.0/3.1 (Bruker). All 2D spectra were processed with TopSpin 2.0/3.1 and analyzed using the software CCP NMR Analysis 2.2.2 (http://www.ccpn.ac.uk/homepage). The data were zero-filled in the t 1 and t 2 dimensions to 512 and 4096 points, respectively. A mixed sine/cosine (4 ¼ p/3 at t ¼ 0) apodization function was used in each dimension. All the spectra were externally referenced to tetramethylsilane in methanol (36) .
To calculate average chemical-shift change ðDdÞ values, 13 C chemicalshifts of isotopically labeled amino acids in Ab 40 fibrils were first subtracted from that of Ab 40 -Cur aggregates. These chemical-shift differences for a, b, and carbonyl carbons (the backbone), and the remaining carbons (the side chain), were then averaged over the number of carbons constituting the backbone and side chain, respectively, to obtain average chemical-shift change ðDdÞ.
Cell viability assay
The cell toxicity assay was performed on 3-day-old rat primary cortical neuronal cultures grown in 96 well plates. All the animal procedures were approved by the TIFR Animal Ethics Committee. On day 4, the primary neurons were incubated with cell culture media containing Ab solutions (4-6 wells each at two different concentrations-first set with 400 mM Ab 40 ) for 48 h. At the end of 48 h, cell media was removed and the cells were washed with Thomson's buffer at pH 7.4 (20 mM HEPES, 146 mM NaCl, 5.4 mM KCl, 2.3 mM CaCl 2 , 0.4 mM KH 2 PO 4 , 0.3 mM Na 2 HPO 4 , 5 mM Glucose). Cells were then incubated with Thomson's buffer (pH~7.4) containing 0.01 mg/mL propidium iodide (PI) for 10 min. PI was removed and cells were washed three times with Thomson's buffer and subsequently fixed with 4% PFA solution. The cells were then imaged for PI under an epifluorescence microscope (Axiovert 200; Carl Zeiss) using a 40Â objective. The images were captured with a charge-coupled device camera (Axiocam; Carl Zeiss). Image analysis was performed for several fields in multiple dishes (at least 12 for each peptide) from three independent repeats and scored for the total number of cells (transmission images) and the number of dead cells (PI fluorescent spots). The ratio of cells that were alive (PI negative) to total cells was reported as viability. The cell viability expressed as percentage was normalized with respect to control cell viability, where the control cell viability was assumed to be 100% (actual viability in control cells was 78 5 3%). Data are expressed as mean 5 SE. Student's t-test was performed to test the significance of the difference of the mean number of deaths from different samples.
RESULTS
We first report the studies highlighting the effect of curcumin and Zn 2þ on the nonstructural aspects, i.e., toxicity, aggregation kinetics, and the nature of the soluble aggregates. Structural details obtained from NMR studies are reported later.
Ab toxicity
The effect of curcumin on Ab 40 -induced toxicity on rat primary cortical neuronal cultures was probed according to the protocol described in the Materials and Methods. The results of the cell viability measurement, expressed as a percentage of the control, are shown in Fig. 1 A. Ab 40 was found to be significantly toxic at a concentration of 400 mM (p < 0.001; Fig. 1 Ab). Presence of 80 mM curcumin significantly reduces the toxicity (p < 0.001; Fig. 1 Ac). However, because curcumin itself reduces the viability at such high concentrations ( Fig. 1 Ad), the assays were also performed using 40 mM of Ab 40 and 8 mM of curcumin maintaining the ratio at 5:1, and still maintaining the Ab concentration well above the saturation concentration (16 mM (37)). The toxicity of 40 mM of Ab 40 is lower but still substantial (p < 0.001; Fig. 1 Ae). A quantity of 8 mM of curcumin significantly reduces this toxicity (p < 0.001; Fig. 1 Af), although it is barely toxic by itself (Fig. 1 Ag) . Similar effects on toxicity have already been reported by us in the case of Ab 42, where 80 mM curcumin alleviates the toxicity induced by 400 mM of Ab 42 to a similar extent (21) . We note that curcumin dose-response curves have been reported earlier, and concentrations in this range were found to be effective in reducing toxicity (17) (18) (19) 38, 39) . The effect of Zn 2þ on the toxicity of Ab 40 and Ab 42 was measured in a similar way. The concentrations of Ab and Zn 2þ used were 100 and 8 mM, respectively. In the case of Ab 40 in presence of Zn 2þ , the viability was 80%; in the case of Ab 42 (p < 0.001; Fig. 1 B) , it was 50%.
Therefore, toxicity measurements do not show any qualitative difference between the effects of curcumin and Zn 2þ on either Ab 40 or Ab 42 .
Size distribution of the soluble oligomers FCS was used to measure the size (hydrodynamic radius) distribution of the soluble species. A quantity of 40 mM Ab containing 100 nM of rhodamine-labeled Ab 40 (RhB-Ab 40 ) was coincubated with 8 mM curcumin. FCS autocorrelation curves were measured 4 h after aggregation was initiated with a pH drop from pH 11 to pH 7.4. The results are shown in Fig. 1 , C and D. The FCS data obtained from 40 mM Ab 40 in presence (triangles) and absence (circles) of curcumin ( Fig. 1 C) were fitted with a quasi-continuous size distribution model using the MEMFCS fitting routine (32) (Fig. 1 D) . Here, the abscissa represents the hydrodynamic radii in nanometer (this axis is calibrated by measuring the diffusion of rhodamine B in water, which has a hydrodynamic radius of 0.57 nm (40)), and the ordinate represents the relative population weighted by the square of the particle brightness (32). The first peak at 2 nm corresponds to the monomeric and the small oligomeric species, while the second peak at~200 nm corresponds to the larger, quasi-stable, soluble aggregates. We observe that the large soluble aggregates are no longer detectable when curcumin is present in the solution (Fig. 1  D) , implying that curcumin accelerates the precipitation of these aggregates and they grow in the precipitate phase. We also observe a small shift and a narrowing of the first peak, which indicate a simultaneous decrease of the population of smaller oligomers.
We have previously shown that Zn 2þ also rapidly precipitates the soluble aggregates of Ab 40 and Ab 42 (23) , indicating that both curcumin and Zn 2þ have similar effects on both the peptides.
TEM measurements of the fibrils
TEM images of Ab 40 and Ab 42 were recorded at two different peptide/curcumin concentrations: 40 mM (Fig. 2 B for Ab 40 ; Fig. 2 E for Ab 42 ) and 400:80 mM (Fig. 2 C for Ab 40 ; Fig. 2 F for Ab 42 ). The Ab 40 aggregates grown in the presence of curcumin do form fibril-like structures, in some cases growing beyond 100 nm (marked by solid rectangles in Fig. 2 ). However, they are much shorter than the fibrils grown without curcumin. In contrast, the aggregates of curcumin-incubated Ab 42 are shorter and more disordered (Fig. 2, E and F) , consistent with what we have previously reported (21) . A measurement of the length distribution of the aggregates of Ab 40 versus Ab 42 quantitatively shows that the average length of the fibrils is indeed much larger for Ab 40 (Fig. S1) . We have earlier shown that Zn 2þ completely disrupts fibril formation (29) . In summary, while both curcumin and Zn 2þ disrupt fibrilization of both the Ab peptides, curcumin-incubated Ab 40 shows less disruption than others.
Atomic-level contacts probed by solid-state NMR
We then probed the atomic-level structural changes in Ab 40 aggregates induced by Zn 2þ and curcumin, respectively, using ssNMR. We designed two different 13 C and 15 N labeled amino-acid schemes to monitor different regions of the peptide including the turn, the tail, and the two hydrophobic arms. Scheme 1 (S1) covers mainly the hydrophobic arms and has Glu 11 measurements on specimens incubated in curcumin for 30 min and four days. We focused on the two distal interresidue contacts established in the mature fibrils of Ab 40 , namely, the contact between F19 and L34, and the saltbridge contact between D23 and K28. It is known that the F19-L34 contact is already established in the early oligomers, but the salt-bridge region appears different in this species (1) . Fig. 3 A shows an overlay of 2D 13 C-13 C PARIS-xy (m ¼ 1, N ¼ 2) spectra of Ab 40 (black online) and Ab 40 -Cur (incubated for four days; red online) aggregates of scheme S1 recorded with 400 ms of mixing time. Fig. 3 B shows the same for Ab 40 (scheme S1) incubated with Zn 2þ . These spectra do not exhibit any drastic changes in peak positions or intensities compared to the spectra obtained from Ab alone. The presence of the cross peak, indicating the spatial contact between aromatic carbons (d/ε/z) of Phe 19 and side-chain carbons (g/d) of Leu 34 (highlighted with dotted square), suggests that the hairpin shape remains largely unperturbed. However, the cross-peak intensity in the case of Ab 40 -Zn 2þ aggregates is weaker than that in the Ab 40 -Cur aggregates. For Ab 42 -Zn 2þ and Ab 42 -Cur, the cross-peak intensities largely remain similar to the wild-type Ab 42 (21, 29) . Overall, curcumin and Zn 2þ do not strongly perturb the core hydrophobic region of either of the peptide variants.
We then probed the changes induced by Zn 2þ on the sample Scheme 2 (S2). Fig. 4 A shows an overlay of 2D 13 C-13 C PARIS-xy (m ¼ 1, N ¼ 0.5) spectra of Ab 40 (black online) and Ab 40 -Zn 2þ (red online) aggregates. Even though the two spectra in Fig. 4 A appear similar, significant changes in the nature (pertaining to conformational changes), chemical shift, as well as the intensity of cross peaks corresponding to amino acids Asp 23 (Fig. 5 D) . Fig. 4 B shows the 1D sum projection extracted from the 2D 13 C-13 C spectra in the carbonyl region of Ab 40 -Zn 2þ . In the case of fibrils grown in the presence of Zn 2þ , the peak corresponding to the salt-bridge-forming carbonyl group (~180 ppm) of the side chain of Asp 23 is replaced by a broad peak (~178 ppm) (29) . Also, the 15 N 1D spectra in Fig. 4 C, 28 side-chain N z seems to be uncharged (41) , which would indicate a local pKa change for the side chain of Lys 28 . However, additional experiments will be required to determine the charge state of N z . Fig. 4, D 23 shows a major peak at 180.5 ppm and a minor peak at 179 ppm (Fig. 5 B) . z-Nitrogen of Lys 28 gives rise to two maxima at 36.2 and 38.3 ppm in Ab 40 aggregates, and similar peaks for Ab 40 -Cur aggregates as well (Fig. 5 C) . Salt-bridge formation was further probed by fs-REDOR measurements between g-carbon of Asp 23 and z-nitrogen of Lys We then tested if the changes observed at four days are present from the early stages of aggregation. We separately recorded 2D 13 C-13 C correlation spectra from the early aggregates (30 min) of Ab 40 , in the presence of curcumin (Fig. 5 E) . We observe that the peak corresponding to the salt-bridge conformation of Asp 23 (~180.4 ppm) is missing at 30 min. Fig. 5 E shows significant similarity in spectra yielded by these 30-min-old Ab 40 -Cur aggregates and the small oligomers of pure Ab 40 (shown in dotted blue online) (1) , showing that initial interaction of curcumin with the small oligomers of Ab 40 is similar to that of Zn 2þ . Fig. 6 shows changes in chemical shifts in the a, b, and carbonyl carbons of all conformations of labeled amino acids in Ab 40 , when aggregated in the presence of Zn 2þ (Fig. 6 A) and curcumin (Fig. 6 B) . The secondary chemical shift data show that in Ab 40 -Zn 2þ aggregates, the b-sheet extends to 1-2 more residues compared to Ab 40 . At the C-terminal, many of the amino acids seem to have , such as V36, M35, A30, and G38. However, there is more structural heterogeneity in the N-terminal region, as indicated by the multiple peaks observed for A2. E11 and V12, which also show stronger and more heterogeneous cross peaks compared to the Ab 40 fibrils. In Ab 40 fibrils the N-terminal b-sheet region starts from the E11 residue and extends up to D23, whereas, in Ab 40 -Zn 2þ , E11 and V12 have one of the conformations in a non-b-sheet state (Fig. S2) . A clear C b -CO cross peak of F20 in Ab 40 -Zn 2þ (Fig. 4 A) suggests a more rigid conformation in the surrounding region, compared to Ab 40 alone. In all the cases, the main difference arises due to changes in the chemical shift of the carbonyl carbon. Ab 42 -Zn 2þ aggregates did not show any chemical shift change or population redistributions (except for D23, K28, and S26 residues) (29) .
Ab 40 -Cur aggregates do not show any strong differences at the N-terminal in comparison with Ab 40 . There is a small chemical shift difference for A2, and for V12 (Fig. 5 A) . In both, the b-sheet starts forming E11 on the N-terminal (Fig. S2) . The backbone of E11, V12, and side chain of V12 and F19 undergo structural changes in the presence of curcumin. As observed in the case of Ab 42 , curcumin has an effect on the chemical shift of V12 and E11 (21) . In the C-terminal, the effect of curcumin on V36 is similar in both Ab 42 (21) and Ab 40 , with curcumin causing population redistribution among two conformers of V36 leading to the total disappearance of V36 0 . However, unlike Ab 42 -Cur (21), we did not see curcumin causing any changes in the spectra of L34 and G38 in Ab 40 . Fig. 6 , C and D, summarizes the structural elements in Ab 40 that appear to interact with Zn 2þ and curcumin, respectively. All amino acids labeled with 13 C and 15 N are marked with double circles. Amino acids that participate in a significant structural change, i.e., those suffering a chemical-shift change of Dd R 0.5 ppm, are highlighted in filled light blue online. Amino acids showing changes in relative population among different structural conformers are highlighted with a dotted red online. Filled green online Asp 23 and Lys 28 that undergo a structural change only in the early oligomers, but not in the mature aggregates. The full table of chemical shifts is provided in Table S1 . 
DISCUSSION
In this work we investigate the structural correlates of Ab toxicity reduction caused by Zn 2þ and curcumin, focusing on the central salt bridge observed in Ab fibrils. Further, we compare these results for both Ab 40 and Ab 42 , to probe the conformational connection between the C-terminal and the central salt bridge. We first establish the reduction of toxicity of the Ab species on which we performed the experiments. We then measure the stability of the soluble oligomers, and the morphology of the mature aggregates, and investigate the atomic level changes in the structure of the hydrophobic core and of the salt-bridge regions of the peptide. As we discuss below, these results lead to a consistent picture of the connection among the state of the salt bridge, the fibril morphology, and toxicity. Most importantly, we find that interactions at the C-terminus can alter the state of the salt bridge, located far away in the sequence, and also in physical distance according to most of the structural models (21, 29) .
Reduction of toxicity is likely due to the precipitation of the oligomeric species FCS measurements described in Fig. 1 suggest that a major effect of curcumin is to precipitate the soluble aggregates of Ab. While the large soluble aggregates (~200 nm) are completely precipitated by curcumin, even the smaller aggregates are affected. Similar observations were made by us (23) when we incubated 8 mM Zn 2þ with 10 and 20 mM Ab 40 (23) . Reports suggest that the soluble aggregation intermediates, and not the final mature fibrils, are responsible for Ab toxicity (43) (44) (45) . Therefore, the sequestration of these species by curcumin and Zn 2þ is likely the key cause of the reduction of toxicity. We note that our results cannot distinguish which of the aggregation intermediates is the most toxic, because both curcumin and Zn 2þ precipitate a large range of aggregates.
Curcumin allows ordered fibril formation
It is known that Zn 2þ strongly disrupts fibril formation for both Ab 42 and Ab 40 (23, 46) . Because Zn 2þ preferentially interacts near the N-terminus (i.e., with histidine residues 6, 13, and 14), it suggests that this region has a strong role to play in determining the state of the salt bridge, located far away both in sequence and in space (29) . On the other hand, Fig. 2 shows that while curcumin shortens the length of Ab 40 fibrils, it does not stop fibril formation altogether. Significantly, it disrupts or reduces the fibril length more in Ab 42 than in Ab 40 (Fig. 2, E and F) . Because its major site of interaction with Ab is at the C-terminal (21) , it indicates that the conformation of the C-terminal can also strongly affect the morphology of the fibrils (21, 29) , and a putative weakening of this interaction in Ab 40 (due to the missing hydrophobic residues I41 and A42) also weakens this effect.
Oligomers retain their hairpin conformation with both curcumin and Zn
2D
Oligomers are characterized by a distal contact formed between F19 and L34, which is retained in the fibril. The row projection of the ssNMR spectra shows the F19-L34 cross peak in Ab 40 incubated with either curcumin (Fig. 3  C) or Zn 2þ (Fig. 3 D) , indicating that the tertiary fold is maintained in the presence of both the reagents. Similar observations were made in the case of Ab 42 earlier (21, 29 (Fig. 4) . Noy et al. (46) have predicted a possible structural perturbation of Ab 40 in the salt-bridge region by Zn 2þ , but the status of the salt bridge was not clear in their study. We have reported before that the salt bridge is absent in the Zn 2þ incubated fibrils of Ab 42 (29) . While this was interpreted as Zn 2þ breaking the salt bridge (29) , it is possible that Zn 2þ simply captures Ab 42 in an oligomeric state that is yet to evolve a stable salt bridge, and keeps it that way. We note that the presence or absence of the salt bridge in the oligomeric form is not yet established for Ab 42. Moreover, recent reports suggest that the terminal A42 and not D23 may form the salt bridge with K28 (8, 9) . However, in Ab 42 containing a C-terminal amide (our preparation), the salt bridge is clearly formed between D23 and K28 (29) . This indicates that different fibrillar polymorphs of the natural peptide probably exist, and small changes in the C-terminal may cause large changes in the nature of the salt bridge.
Curcumin allows the salt bridge to form in Ab 40 Our results show that the salt bridge is present in the curcumin-incubated fibrils of Ab 40 (Fig. 5 ). This gives rise to two possibilities: either curcumin induces immediate salt-bridge formation in the oligomers, or it allows salt-bridge formation at a later stage, when the fibrils form. To decide between these possibilities, we looked at the Ab aggregates precipitated by curcumin at an early stage (30 min). We found that the salt-bridge-forming peaks of Asp 23 are absent at this stage (Fig. 5 E) , indicating that curcumin allows saltbridge formation only at a later stage. However, for Ab 42 , curcumin does not allow formation of the salt bridge or of well-ordered fibrils even in the later stage.
It is interesting to speculate why curcumin allows Ab 40 to form the salt bridge at a later stage of growth. We have found earlier that curcumin interacts strongly with the 34th, 36th, and 38th residues on the C-terminal of Ab 42 (21) . However, here we do not observe any substantial change induced by curcumin in L34 and G38 of Ab 40 . This indicates that interaction of Ab 40 with curcumin is much weaker than that with Ab 42 . Two additional hydrophobic residues (I41 and A42) on the C-terminal thus seem to play a crucial role in the way Ab interacts with curcumin. It is likely that a stronger interaction of curcumin with these extra two amino acids in Ab 42 prevents the formation of the salt bridge, but a weaker restriction imposed on the Ab 40 molecules allows the aggregation to proceed such that the peptide ultimately forms the salt bridge. We note that it is possible that curcumin has a much lower affinity for the mature aggregates of Ab 40 , and may tend to dissociate from them as the aggregates mature. In contrast, Zn 2þ likely interacts with the histidine-containing N-terminal region of Ab (25) (26) (27) , which is identical in sequence in both Ab 40 and Ab 42 , and consequently has the same effect on both.
Significantly, the fibril morphology seems to be correlated with the presence of the salt bridge. Zn 2þ -incubated samples never form regular fibrils (23, 46) , while curcumin-incubated ones do form fibril-like features, though of a shorter length (Fig. 2) . It has also been shown by others recently that Ab 40 is able to form fibrils in the presence of curcumin (18) . There are also reports on other phenolic compounds that can interact with Ab 40 in the C-terminal, and still allow salt-bridge formation between D23 and K28 (47).
CONCLUSIONS
We conclude that both Zn 2þ and curcumin reduce Ab toxicity by precipitating the non-salt-bridged oligomers. However, curcumin eventually allows the formation of the salt bridge in Ab 40 , likely due to its weaker C-terminalmediated interaction with the peptide. This shows the strong effect of the C-terminal residues on the D23-K28 salt bridge, which is far removed from it in the sequence. The effects of Zn 2þ indicate that the N-terminal also can have a similar effect on the central salt bridge. Thus the N-terminal, the C-terminal, and the central salt bridge containing regions of Ab appear to have a clear conformational link. This helps to explain several known facts about Ab toxicity. First, this conformational link suggests that Ab 42 can be more toxic than the shorter Ab 40 by differently controlling the salt-bridge region, which possibly plays a major role in determining the toxicity of these peptides. It also suggests that most of the mutations leading to early onset AD may actually reflect different facets of a unified toxicity mechanism. In addition, it appears that curcumin preferentially interacts with Ab 40 aggregation intermediates, and changes their toxicity-but does not strongly interact with the mature end-product of aggregation. Thus, curcumin can be a starting point for developing a catalytic agent that can modulate the aggregation pathway, reducing toxicity without a net thermodynamic cost. Two figures and one table are available 
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